Pharma and Irish inversions: Increasing your share price

May 31 2014

A spate of recent examples indicates that inversion transactions are as popular as they have ever been, with Pfizer’s attempted deal with AstraZeneca highlighting that companies in the pharmaceuticals industry are increasingly using the inversion option. William Fry Tax Advisors, the Irish member firm of Taxand, look at why this is, and analyse why Ireland is proving to be the location of choice for newly-formed companies post-inversion.

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

more across site & shared bottom lb ros

More from across our site

Direct Tax

This week in tax: IRS has lost 11% of its workforce, report finds

The cuts disproportionately affected staff in certain positions, the report also found; in other news, MHA announced the €24 million acquisition of Baker Tilly South East Europe

Sam Sholli, May 09 2025

Transfer Pricing

India sets APA resolution targets in 2025/26 action plan

The plan aims to improve the efficiency, transparency, and effectiveness of direct tax administration in India

Sam Sholli, May 08 2025

Direct Tax

Part of Eton College viewed from playing fields

This month in indirect tax: UK denies private school VAT breaches human rights law

Meanwhile, South Africa’s finance minister has accepted a court decision on suspending a VAT increase and US President Donald Trump mulls a 100% tariff on foreign films

Sam Sholli, May 07 2025

Direct Tax

Jaime Carey, president of the International Bar Association

IBA president: OECD’s two-pillar solution is ‘crucial’

Jaime Carey speaks about the benefits of his tax background, DEI values, the use of AI for a smarter legal practice, and other priorities that will define his presidency

Noemi Distefano, May 06 2025

Direct Tax